Clinical Trial

A Retrospective Study on the Factors of Drug-coated Balloon Restenosis

Study acronym: RE-DCB
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 14, 2024 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to analyze potential factors post paclitaxel drug-coated balloon angioplasty in patients with Denovo large vessels disease. It includes imaging endpoints and clinical event endpoints. Over 5000 patients are expected to be enrolled.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-28.
Status change: Not Yet Recruiting → Recruiting 2024-11-12
Trial Details
NCT Number NCT06620458
Lead Sponsor Henan Institute of Cardiovascular Epidemiology
Conditions Coronary Artery Disease
Enrollment 5,000 participants
Start Date 2024-10-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-14